Morgan Keegan Starts Coverage on 10 Healthcare Stocks: ABT, BSX, STJ at Outperform, JNJ, MDT at Market Perform
- Market Wrap: Markets Slump Amid Weak Econ. Data; GoDaddy Goes Public; U.S. Auto Sales Mixed in March
- McDonald's (MCD) Announces Enhanced Employee Benefits; Includes Wage Increase, Paid Vacation
- After-Hours Stock Movers 04/01: (RPRX) (TCPI) (XON) Higher; (SIGM) (CNAT) (MU) Lower (more...)
- Micron Technology (MU) Tops Q2 EPS by 8c
- Tesla (TSLA) Announces Model 'W'
In the Healthcare group Friday morning, Morgan Keegan's Jan Wald initiated coverage on the following stocks:
- Abbott Labs (NYSE: ABT) with an Outperform rating and a $61 price target
- Boston Scientific (NYSE: BSX) with an Outperform rating and a $8 price target
- St. Jude (NYSE: STJ) with an Outperform rating and a $60 price target
- DexCom (Nasdaq: DXCM) with an Outperform rating and a $18 price target
- HeartWare (Nasdaq: HTWR) with an Outperform rating and a $87 price target
- J&J (NYSE: JNJ) with a Market Perform rating and a $70 price target
- Medtronic (NYSE: MDT) with a Market Perform rating and a $43 price target
- Edwards Lifesciences (NYSE: EW) with a Market Perform rating and a $97 price target
- Thoratec (Nasdaq: THOR) with a Market Perform rating and a $35 price target
- AtriCure (Nasdaq: ATRC) with a Market Perform rating and a $14 price target
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FBR Capital Starts Agile Therapeutics (AGRX) at Outperform
- Macquarie Starts Cinedigm Digital Cinema (CIDM) at Neutral
- FBR Capital Starts Acceleron Pharma (XLRN) at Outperform
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesMorgan Keegan & Company
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!